Abstract:Intestinal dysmotility is common in many diseases and is correlated with gut microbiota dysbiosis and systemic inflammation. Functional constipation (FC) is the most typical manifestation of intestinal hypomotility and reduces patients’ quality of life. Some studies have reported that fecal micriobiota transplantation (FMT) may be an effective and safe therapy for FC as it corrects intestinal dysbiosis. This study was conducted to evaluate how FMT remodels the gut microbiome and to determine a possible correlation between certain microbes and clinical symptoms in constipated individuals. Data were retrospectively collected on 18 patients who underwent FMT between January 1, 2019 and June 30, 2020. The fecal bacterial genome was detected by sequencing the V3–V4 hypervariable regions of the 16S rDNA gene. Fecal short chain fatty acids (SCFAs) were detected by gas chromatography-mass spectrometry, and serum inflammatory factor concentrations were detected via enzyme-linked immunosorbent assay. Comparing the changes in fecal microbiome compositions before and after FMT revealed a significant augmentation in the alpha diversity and increased abundances of some flora such as Clostridiales, Fusicatenibacter , and Paraprevotella . This was consistent with the patients experiencing relief from their clinical symptoms. Abundances of other flora, including Lachnoanaerobaculum , were decreased, which might correlate with the severity of patients’ constipation. Although no differences were found in SCFA production, the butyric acid concentration was correlated with both bacterial alterations and clinical symptoms. Serum IL-8 levels were significantly lower after FMT than at baseline, but IL-4, IL-6, IL-10, and IL-12p70 levels were not noticeably changed. This study showed how FMT regulates the intestinal microenvironment and affects systemic inflammation in constipated patients, providing direction for further research on the mechanisms of FMT. It also revealed potential microbial targets for precise intervention, which may bring new breakthroughs in treating constipation.

[Expression of TMEM16A in the colon of intractable functional constipation patients and its clinical implications].

Osmotic Pressure Induces Translocation of Aquaporin-8 by P38 and JNK MAPK Signaling Pathways in Patients with Functional Constipation.

The edible <i>Lactobacillus paracasei</i> X11 with Konjac glucomannan promotes intestinal motility in zebrafish

Activation of TMEM16A by natural product canthaxanthin promotes gastrointestinal contraction

Significance of TMEM16A Expression in Colorectal Carcinoma

Identification of evodiamine and rutecarpine as novel TMEM16A inhibitors and their inhibitory effects on peristalsis in isolated Guinea-pig ileum

Entering the spotlight: Chitosan oligosaccharides as novel activators of CaCCs/TMEM16A

Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: a proteomic study.

Cystic fibrosis transmembrane conductance regulator modulates enteric cholinergic activities and is abnormally expressed in the enteric ganglia of patients with slow transit constipation

Decreased Enteric Fatty Acid Amide Hydrolase Activity is Associated with Colonic Inertia in Slow Transit Constipation

The TMEM63B Channel Facilitates Intestinal Motility and Enhances Proliferation of Intestinal Stem Cells

Potential Role of Fecal Microbiota from Patients with Slow Transit Constipation in the Regulation of Gastrointestinal Motility

Colonic TRPV4 overexpression is related to constipation severity

Study on gastrointestinal motility in slow transit constipation

Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation

Gut Microbiota and Metabolite Profiles Associated With Functional Constipation Severity

Study on Colonic Transit Function, Gastrointestinal Hormones and Nitric Oxide Synthase in Different Types of Functional Constipation Patients

Clinical application of transcranial magnetic stimulation for functional bowel disease

The Role of 5-HT7 Receptor in Modulation of Intestinal Motility

TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer

Roles of Gut Microbiota and Metabolites in Pathogenesis of Functional Constipation